MetLife, Inc. (NYSE:MET) Receives $92.58 Consensus Target Price from Analysts
Shares of MetLife, Inc. (NYSE:MET – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1 year […]
Shares of MetLife, Inc. (NYSE:MET – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve research firms that are covering the company, Marketbeat reports. One investment analyst has rated the stock with a hold recommendation and eleven have given a buy recommendation to the company. The average 1 year […]
